This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2021 Aug 19;138(7):504-506.

doi: 10.1182/blood.2021012299.

AML onco-niche: villain or ally?

Marta Derecka¹

Affiliations

PMID: 34410356
DOI: 10.1182/blood.2021012299

Free article

Comment

AML onco-niche: villain or ally?

Marta Derecka. Blood. 2021.

Free article

. 2021 Aug 19;138(7):504-506.

doi: 10.1182/blood.2021012299.

Author

Marta Derecka¹

Affiliation

¹ St Jude Children's Research Hospital.

PMID: 34410356
DOI: 10.1182/blood.2021012299

No abstract available

PubMed Disclaimer

Comment on

Targeting the plasticity of mesenchymal stromal cells to reroute the course of acute myeloid leukemia.
Borella G, Da Ros A, Borile G, Porcù E, Tregnago C, Benetton M, Marchetti A, Bisio V, Montini B, Michielotto B, Cani A, Leszl A, Campodoni E, Sandri M, Montesi M, Bresolin S, Cairo S, Buldini B, Locatelli F, Pigazzi M. Borella G, et al. Blood. 2021 Aug 19;138(7):557-570. doi: 10.1182/blood.2020009845. Blood. 2021. PMID: 34010415

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems
Medical
- MedlinePlus Health Information